NO992298L - Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse - Google Patents

Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse

Info

Publication number
NO992298L
NO992298L NO992298A NO992298A NO992298L NO 992298 L NO992298 L NO 992298L NO 992298 A NO992298 A NO 992298A NO 992298 A NO992298 A NO 992298A NO 992298 L NO992298 L NO 992298L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
analogs
conformationally limited
conformationally
Prior art date
Application number
NO992298A
Other languages
English (en)
Norwegian (no)
Other versions
NO992298D0 (no
Inventor
Rumi Delansorne
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO992298D0 publication Critical patent/NO992298D0/no
Publication of NO992298L publication Critical patent/NO992298L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
NO992298A 1996-11-14 1999-05-12 Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse NO992298L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96402441A EP0842946A1 (de) 1996-11-14 1996-11-14 LHRH Analoge mit starrer Konformation, deren Verwendungen und pharmazeutische Zusammensetzungen
PCT/EP1997/006322 WO1998021229A1 (en) 1996-11-14 1997-11-12 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO992298D0 NO992298D0 (no) 1999-05-12
NO992298L true NO992298L (no) 1999-07-08

Family

ID=8225315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992298A NO992298L (no) 1996-11-14 1999-05-12 Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse

Country Status (28)

Country Link
US (1) US6153587A (de)
EP (2) EP0842946A1 (de)
JP (1) JP2001503444A (de)
KR (1) KR20000068975A (de)
CN (1) CN1237979A (de)
AP (1) AP9901529A0 (de)
AT (1) ATE196914T1 (de)
AU (1) AU5481798A (de)
BR (1) BR9713060A (de)
CA (1) CA2270158A1 (de)
CO (1) CO4930283A1 (de)
CZ (1) CZ172899A3 (de)
DE (1) DE69703308D1 (de)
EE (1) EE9900174A (de)
HU (1) HUP0000249A3 (de)
ID (1) ID21990A (de)
IL (1) IL129821A0 (de)
JO (1) JO1999B1 (de)
MA (1) MA26447A1 (de)
NO (1) NO992298L (de)
NZ (1) NZ335454A (de)
OA (1) OA11045A (de)
PE (1) PE16899A1 (de)
PL (1) PL333358A1 (de)
TN (1) TNSN97173A1 (de)
TR (1) TR199901054T2 (de)
WO (1) WO1998021229A1 (de)
ZA (1) ZA9710254B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
EP0842946A1 (de) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. LHRH Analoge mit starrer Konformation, deren Verwendungen und pharmazeutische Zusammensetzungen
EP0882736A1 (de) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Peptidanaloge des LH-RH, ihre Verwendungen und die sie enthaltenden pharmazeutischen Zusammensetzungen
EP0998940A1 (de) * 1998-09-30 2000-05-10 Laboratoire Theramex Pharmazeutische zusammensetzung basierend auf alpha-cyclodextrin für die orale verabreichung von LH-RH analogen
KR100679878B1 (ko) * 1999-04-26 2007-02-07 아지노모토 가부시키가이샤 멜라노사이트-자극 호르몬 억제제
US8821943B2 (en) * 2006-09-12 2014-09-02 Board Of Regents Of The University Of Nebraska Methods and compositions for targeted delivery of therapeutic agents
US20230374071A1 (en) * 2020-10-08 2023-11-23 Dignify Therapeutics, Llc Compositions for inducing urinary voiding and defecation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0842946A1 (de) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. LHRH Analoge mit starrer Konformation, deren Verwendungen und pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
CN1237979A (zh) 1999-12-08
CO4930283A1 (es) 2000-06-27
ID21990A (id) 1999-08-19
JO1999B1 (en) 1999-05-15
KR20000068975A (ko) 2000-11-25
US6153587A (en) 2000-11-28
OA11045A (en) 2003-03-07
TNSN97173A1 (fr) 2005-03-15
EP0937101A1 (de) 1999-08-25
EE9900174A (et) 1999-12-15
ZA9710254B (en) 1998-05-28
NO992298D0 (no) 1999-05-12
WO1998021229A1 (en) 1998-05-22
BR9713060A (pt) 2000-04-11
PL333358A1 (en) 1999-12-06
PE16899A1 (es) 1999-02-19
CZ172899A3 (cs) 1999-08-11
ATE196914T1 (de) 2000-10-15
HUP0000249A3 (en) 2000-11-28
AU5481798A (en) 1998-06-03
AP9901529A0 (en) 1999-06-30
CA2270158A1 (en) 1998-05-22
MA26447A1 (fr) 2004-12-20
IL129821A0 (en) 2000-02-29
EP0937101B1 (de) 2000-10-11
DE69703308D1 (de) 2000-11-16
TR199901054T2 (xx) 1999-07-21
JP2001503444A (ja) 2001-03-13
EP0842946A1 (de) 1998-05-20
NZ335454A (en) 2000-10-27
HUP0000249A2 (en) 2000-07-28

Similar Documents

Publication Publication Date Title
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
ES2154167A1 (es) Aminoderivados ciclicos antagonistas del receptor ccr-3.
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
BR0012243A (pt) Triflúor butenos nematocidas
BG102172A (en) New stable medicamentous compositions for the preparation of propellant-free aerosols
EA200100519A1 (ru) Композиции на основе тонкоизмельченного эплеренона
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
EP0695171A1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
ATE231872T1 (de) Thiazolopyrimidinderivate
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
TR200000152T2 (tr) Yeni bileşikler.
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
BG104916A (en) Calcilytic compounds
BR0016952A (pt) Compostos derivados de fenil-piperazina substituìdos, composição farmacêutica, uso e método
AR015945A1 (es) Composiciones de spray para el cabello autofobicas
PT1024809E (pt) Utilizacao de agentes de imunomodulacao
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application